Integrating psychopharmacology and psychotherapy to treat children with ADHD

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMORIYAMA, T. S.
dc.contributor.authorPOLANCZYK, G. V.
dc.contributor.authorTERZI, F. S.
dc.contributor.authorFARIA, K. M.
dc.contributor.authorDöPFNER, M.
dc.contributor.authorROHDE, L. A.
dc.date.accessioned2023-02-09T19:59:41Z
dc.date.available2023-02-09T19:59:41Z
dc.date.issued2013
dc.identifier.citationMoriyama, T. S.; Polanczyk, G. V.; Terzi, F. S.; Faria, K. M.; Döpfner, M.; Rohde, L. A.. Integrating psychopharmacology and psychotherapy to treat children with ADHD. In: . INTEGRATING PSYCHOTHERAPY AND PSYCHOPHARMACOLOGY: A HANDBOOK FOR CLINICIANS: TAYLOR AND FRANCIS, 2013. p.161-185.
dc.identifier.isbn9780203117323; 9780415529976
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/51143
dc.language.isoeng
dc.publisherTAYLOR AND FRANCIS
dc.relation.ispartofINTEGRATING PSYCHOTHERAPY AND PSYCHOPHARMACOLOGY: A HANDBOOK FOR CLINICIANS
dc.rightsrestrictedAccess
dc.rights.holderCopyright TAYLOR AND FRANCIS
dc.titleIntegrating psychopharmacology and psychotherapy to treat children with ADHD
dc.typebookPart
dc.type.categorybook chapter
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryisode
hcfmusp.author.externalDöPFNER, M.:Department of Child and Adolescent Psychiatry and Psychotherapy, University Clinic, Cologne, Germany
hcfmusp.author.externalROHDE, L. A.:National Institute of Developmental Psychiatry for Children and Adolescents, INCT-CNPq, Porto Alegre, RS, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcTAIS SILVEIRA MORIYAMA
hcfmusp.contributor.author-fmusphcGUILHERME VANONI POLANCZYK
hcfmusp.contributor.author-fmusphcFERNANDA SILVA TERZI
hcfmusp.contributor.author-fmusphcKAUY VICTOR MARTINEZ FARIA
hcfmusp.description.beginpage161
hcfmusp.description.endpage185
hcfmusp.origemSCOPUS
hcfmusp.origem.scopus2-s2.0-85086495776
hcfmusp.relation.referenceAbikoff, H., Hechtman, L., Klein, R.G., Gallagher, R., Fleiss, K., Etcovitch, J., Pollack, S., Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment (2004) Journal of the American Academy of Child and Adolescent Psychiatry, 43, pp. 820-829
hcfmusp.relation.referenceAbikoff, H., Hechtman, L., Klein, R.G., Weiss, G., Fleiss, K., Etcovitch, J., Pollack, S., Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment (2004) Journal of the American Academy of Child and Adolescent Psychiatry, 43, pp. 802-811
hcfmusp.relation.referenceADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents (2011) Pediatrics, 128, pp. 1007-1022
hcfmusp.relation.reference(1994) Diagnostic and Statistical Manual of Mental Disorders, , (4th ed.). Washington, DC: American Psychiatric Press
hcfmusp.relation.referenceAntshel, K.M., Barkley, R., Psychosocial interventions in attention deficit hyperactivity disorder (2008) Child and Adolescent Psychiatric Clinics of North America, 17, pp. 421-437
hcfmusp.relation.referenceBarkley, R.A., Cox, D., A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance (2007) Journal of Safety Research, 38, pp. 113-128
hcfmusp.relation.referenceBarkley, R.A., Fischer, M., The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults (2010) Journal of the American Academy of Child and Adolescent Psychiatry, 49, pp. 503-513
hcfmusp.relation.referenceBauermeister, J.J., So, C.Y., Jensen, P.S., Krispin, O., El Din, A.S., Development of adaptable and flexible treatment manuals for externalizing and internalizing disorders in children and adolescents (2006) Revista Brasileira de Psiquiatria, 28, pp. 67-71
hcfmusp.relation.referenceBiederman, J., Melmed, R.D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/ hyperactivity disorder (2008) Pediatrics, 121
hcfmusp.relation.referenceBjornstad, G., Montgomery, P., Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents (2005) Cochrane Database of Systematic Reviews, 2, p. CD005042
hcfmusp.relation.referenceCastells, X., Ramos-Quiroga, J.A., Bosch, R., Nogueira, M., Casas, M., Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults (2011) Cochrane Database of Systematic Reviews, 6, p. CD007813
hcfmusp.relation.referenceCheng, J.Y., Chen, R.Y., Ko, J.S., Ng, E.M., Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis (2007) Psychopharmacology, 194, pp. 197-209
hcfmusp.relation.referenceCherland, E., Fitzpatrick, R., Psychotic side effects of psychostimulants: A 5-year review (1999) Canadian Journal of Psychiatry, 44, pp. 811-813
hcfmusp.relation.referenceClements, S.D., Peters, J.E., Minimal brain dysfunctions in the school-age child. Diagnosis and treatment (1962) Archives of General Psychiatry, 6, pp. 185-197
hcfmusp.relation.referenceConnor, D.F., Fletcher, K.E., Swanson, J.M., A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder (1999) Journal of the American Academy of Child and Adolescent Psychiatry, 38, pp. 1551-1559
hcfmusp.relation.referenceDopfner, M., Psychosocial and other non-pharmacological treatments (2010) ADHD and hyperkinetic disorder, pp. 77-90. , In T. Banaschewski, D. Coghill, M. Danck-aerts, M. Dopfner, L. A. Rohde, J. A. Sergeant, E. J. S. Sonuga-Barke, E. Taylor, & A. Zuddas (Eds.), Oxford: Oxford University Press
hcfmusp.relation.referenceDopfner, M., Breuer, D., Schurmann, S., Metternich, T.W., Rademacher, C., Lehmkuhl, G., Effectiveness of an adaptive multimodal treatment in children with attention-deficit hyperactivity disorder-global outcome (2004) European Child & Adolescent Psychiatry, 13 (1), pp. 117-129
hcfmusp.relation.referenceElia, J., Vetter, V.L., Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: What is known and how should it influence prescribing in children? (2010) Paediatric Drugs, 12, pp. 165-175
hcfmusp.relation.referenceFabiano, G.A., Pelham, W.E., Jr., Coles, E.K., Gnagy, E.M., Chronis-Tuscano, A., O'Connor, B.C., A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder (2009) Clinical Psychology Review, 29, pp. 129-140
hcfmusp.relation.referenceFaraone, S.V., Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths (2009) P & T: A Peer-Reviewed Journal for Formulary Management, 34, pp. 678-694
hcfmusp.relation.referenceFaraone, S.V., Biederman, J., Efficacy of Adderall for attention-deficit/hyperactivity disorder: A meta-analysis (2002) Journal of Attention Disorders, 6, pp. 69-75
hcfmusp.relation.referenceFaraone, S.V., Biederman, J., Mick, E., The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies (2006) Psychological Medicine, 36, pp. 159-165
hcfmusp.relation.referenceFaraone, S.V., Biederman, J., Morley, C.P., Spencer, T.J., Effect of stimulants on height and weight: A review of the literature (2008) Journal of the American Academy of Child and Adolescent Psychiatry, 47, pp. 994-1009
hcfmusp.relation.referenceFaraone, S.V., Biederman, J., Roe, C., Comparative efficacy of Adderall and methylphenidate in attention-deficit/ hyperactivity disorder: A meta-analysis (2002) Journal of Clinical Psychopharmacology, 22, pp. 468-473
hcfmusp.relation.referenceFaraone, S.V., Biederman, J., Spencer, T.J., Aleardi, M., Comparing the efficacy of medications for ADHD using meta-analysis (2006) Medscape General Medicine, 8, p. 4
hcfmusp.relation.referenceFaraone, S.V., Buitelaar, J., Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis (2010) European Child & Adolescent Psychiatry, 19, pp. 353-364
hcfmusp.relation.referenceGeller, D., Donnelly, C., Lopez, F., Rubin, R., Newcorn, J., Sutton, V., Sumner, C., Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder (2007) Journal of the American Academy of Child and Adolescent Psychiatry, 46, pp. 1119-1127
hcfmusp.relation.referenceHanwella, R., Senanayake, M., de Silva, V., Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis (2011) BMC Psychiatry, 11, p. 176
hcfmusp.relation.referenceHazell, P.L., Kohn, M.R., Dickson, R., Walton, R.J., Granger, R.E., Wyk, G.W., Core ADHD symptom improvement with atomoxetine versus methylphenidate: A direct comparison meta-analysis (2011) Journal of Attention Disorders, 15, pp. 674-683
hcfmusp.relation.referenceJain, R., Segal, S., Kollins, S.H., Khayrallah, M., Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder (2011) Journal of the American Academy of Child and Adolescent Psychiatry, 50, pp. 171-179
hcfmusp.relation.referenceKattimani, S., Mahadevan, S., Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy (2011) Annals of Indian Academy of Neurology, 14, pp. 9-11
hcfmusp.relation.referenceKlassen, A., Miller, A., Raina, P., Lee, S.K., Olsen, L., Attention-deficit hyperactivity disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies (1999) Canadian Journal of Psychiatry, 44, pp. 1007-1016
hcfmusp.relation.referenceKollins, S.H., Jain, R., Brams, M., Segal, S., Findling, R.L., Wigal, S.B., Khayrallah, M., Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD (2011) Pediatrics, 127
hcfmusp.relation.referenceKratochvil, C.J., Wilens, T.E., Greenhill, L.L., Gao, H., Baker, K.D., Feldman, P.D., Gelowitz, D.L., Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder (2006) Journal of the American Academy of Child and Adolescent Psychiatry, 45, pp. 919-927
hcfmusp.relation.referenceLawson, K.A., Johnsrud, M., Hodgkins, P., Sasane, R., Crismon, M.L., Utilization patterns of stimulants in ADHD in the Medicaid population: A retrospective analysis of data from the Texas Medicaid program (2012) Clinical Therapeutics, 34, pp. 944-956
hcfmusp.relation.referenceMajewicz-Hefley, A., Carlson, J.S., A meta-analysis of combined treatments for children diagnosed with ADHD (2007) Journal of Attention Disorders, 10, pp. 239-250
hcfmusp.relation.referenceMannuzza, S., Klein, R.G., Bessler, A., Malloy, P., Hynes, M.E., Educational and occupational outcome of hyperactive boys grown up (1997) Journal of the American Academy of Child and Adolescent Psychiatry, 36, pp. 1222-1227
hcfmusp.relation.referenceMannuzza, S., Klein, R.G., Bessler, A., Malloy, P., LaPadula, M., Adult psychiatric status of hyperactive boys grown up (1998) American Journal of Psychiatry, 155, pp. 493-498
hcfmusp.relation.referenceMarcus, S.C., Wan, G.J., Kemner, J.E., Olfson, M., Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder (2005) Archives of Pediatrics & Adolescent Medicine, 159, pp. 572-578
hcfmusp.relation.referenceMolina, B.S., Hinshaw, S.P., Swanson, J.M., Arnold, L.E., Vitiello, B., Jensen, P.S., The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study (2009) Journal of the American Academy of Child and Adolescent Psychiatry, 48 (5), pp. 484-500
hcfmusp.relation.referenceA 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD (1999) Archives of General Psychiatry, 56, pp. 1073-1086
hcfmusp.relation.referenceNair, V., Mahadevan, S., Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD (2009) Journal of Tropical Pediatrics, 55, pp. 116-121
hcfmusp.relation.reference(2008) Attention deficit hyperactivity disorder diagnosis and management of ADHD in children, young people and adults, , http://www.nice.org.uk/nicemedia/live/12061/42059/42059.pdf
hcfmusp.relation.referencePalli, S.R., Kamble, P.S., Chen, H., Aparasu, R.R., Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder (2012) Journal of Child and Adolescent Psychopharmacology, 22, pp. 139-148
hcfmusp.relation.referencePeterson, K., McDonagh, M.S., Fu, R., Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: A systematic review and indirect comparison meta-analysis (2008) Psycho-pharmacology, 197, pp. 1-11
hcfmusp.relation.referencePliszka, S., Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (2007) Journal of the American Academy of Child and Adolescent Psychiatry, 46, pp. 894-921
hcfmusp.relation.referencePolanczyk, G., de Lima, M.S., Horta, B.L., Biederman, J., Rohde, L.A., The worldwide prevalence of ADHD: A systematic review and metaregression analysis (2007) American Journal of Psychiatry, 164, pp. 942-948
hcfmusp.relation.referenceRemschmidt, H., Global consensus on ADHD/HKD (2005) European Child & Adolescent Psychiatry, 14, pp. 127-137
hcfmusp.relation.referenceRoss, R.G., Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder (2006) The American Journal of Psychiatry, 163, pp. 1149-1152
hcfmusp.relation.referenceSallee, F.R., McGough, J., Wigal, T., Donahue, J., Lyne, A., Biederman, J., Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: A placebo-controlled trial (2009) Journal of the American Academy of Child and Adolescent Psychiatry, 48, pp. 155-165
hcfmusp.relation.referenceSchachter, H.M., Pham, B., King, J., Langford, S., Moher, D., How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis (2001) Canadian Medical Association Journal, 165, pp. 1475-1488
hcfmusp.relation.referenceSpencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., Griffin, S., Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle (1996) Journal of the American Academy of Child and Adolescent Psychiatry, 35, pp. 409-432
hcfmusp.relation.referenceStein, M.A., Impairment associated with adult ADHD (2008) CNS Spectrums, 13 (8), pp. 9-11
hcfmusp.relation.referenceStiefel, G., Besag, F.M., Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder (2010) Drug Safety, 33, pp. 821-842
hcfmusp.relation.referenceStorebo, O.J., Skoog, M., Damm, D., Thomsen, P.H., Simonsen, E., Gluud, C., Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years (2011) Cochrane Database of Systematic Reviews, 12, p. CD008223
hcfmusp.relation.referenceTaylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Zuddas, A., European clinical guidelines for hyperkinetic disorder-first upgrade (2004) European Child & Adolescent Psychiatry, 13 (1), pp. 17-30
hcfmusp.relation.referencevan der Oord, S., Prins, P.J., Oosterlaan, J., Emmelkamp, P.M., Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: A meta-analysis (2008) Clinical Psychology Review, 28, pp. 783-800
hcfmusp.relation.referenceWinterstein, A.G., Gerhard, T., Shuster, J., Zito, J., Johnson, M., Liu, H., Saidi, A., Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database (2008) Annals of Pharmacotherapy, 42, pp. 24-31
hcfmusp.relation.reference(1993) The ICD-10 classification of mental and behavioral disorders: Diagnostic criteria for research, , Geneva: Author
hcfmusp.relation.referenceZwi, M., Jones, H., Thorgaard, C., York, A., Dennis, J.A., Parent training interventions for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years (2011) Cochrane Database of Systematic Reviews, 12, p. CD003018
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication3f19f037-d730-4e2f-9059-8931bf3c51f2
relation.isAuthorOfPublication107c1ba9-764d-461e-aa8d-0dee86ca590e
relation.isAuthorOfPublicationf9b2514b-434f-4665-9df2-b580095230db
relation.isAuthorOfPublication6ad43c9d-f9a6-42dc-97ae-4be62d503f6e
relation.isAuthorOfPublication.latestForDiscovery3f19f037-d730-4e2f-9059-8931bf3c51f2
Arquivos
Coleções
Livros e Capítulos de Livros - FM/MPS
Livros e Capítulos de Livros - HC/IPq
Livros e Capítulos de Livros - LIM/21